ConductScience.org, home

Paper6819085

Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.

Shen-Ong GL and 3 others. Cell, 1982. Cited by 459 papers, by iCite.

Cite this record

ConductScience Library. Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas. Papers, record 6819085. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6819085

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Novel myc oncogene RNA from abortive immunoglobulin-gene recombination in mouse plasmacytomas.
PubMed
Journal
Cell
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
459
iCite
Relative citation ratio, by iCite
8.49
iCite
Revised in PubMed
2019-07-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shen-Ong GLG L
2Keath EJE J
3Piccoli SPS P
4Cole MDM D

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ImmunoglobulinsMajor topic
OncogenesMajor topic
PlasmacytomaMajor topic
RNA, NeoplasmMajor topic
Animals
Cell Line
Cells, Cultured
Cloning, Molecular
DNA, Recombinant
Immunoglobulin Constant Regions
Immunoglobulin Heavy Chains
Mice
Nucleic Acid Hybridization

Source PubMed

Download CSV of topics

Cited by152

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 459 citations.

PMIDTitleJournalYearIn PapersSource
41832173DIS3 mutations enhance AID-driven translocations during B-cell activation, promoting transformation to multiple myeloma.Nat Commun2026https://conductscience.org/library/papers/41832173PubMed
40204952The BCL-2 protein family: from discovery to drug development.Cell Death Differ2025https://conductscience.org/library/papers/40204952PubMed
39674742Immunocompetent mouse models of multiple myeloma.Semin Hematol2025https://conductscience.org/library/papers/39674742PubMed
39160158Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity.Blood Cancer J2024https://conductscience.org/library/papers/39160158PubMed
38233233Immunocompetent Mouse Models of Multiple Myeloma: Therapeutic Implications.Hematol Oncol Clin North Am2024https://conductscience.org/library/papers/38233233PubMed
34149703Laboratory Mice - A Driving Force in Immunopathology and Immunotherapy Studies of Human Multiple Myeloma.Front Immunol2021https://conductscience.org/library/papers/34149703PubMed
29467490Targeting MYC in multiple myeloma.Leukemia2018https://conductscience.org/library/papers/29467490PubMed
28590415The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance.Genes (Basel)2017https://conductscience.org/library/papers/28590415PubMed
24845460Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma.Immunol Res2014https://conductscience.org/library/papers/24845460PubMed
24692190c-MYC-induced genomic instability.Cold Spring Harb Perspect Med2014https://conductscience.org/library/papers/24692190PubMed
24384812An overview of MYC and its interactome.Cold Spring Harb Perspect Med2014https://conductscience.org/library/papers/24384812PubMed
22558003The 8q24 gene desert: an oasis of non-coding transcriptional activity.Front Genet2012https://conductscience.org/library/papers/22558003PubMed
22546857CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.J Clin Invest2012https://conductscience.org/library/papers/22546857PubMed
22373487Two sides of the Myc-induced DNA damage response: from tumor suppression to tumor maintenance.Cell Div2012https://conductscience.org/library/papers/22373487PubMed
21779457Myc: the beauty and the beast.Genes Cancer2010https://conductscience.org/library/papers/21779457PubMed
19603522Colocalization of somatic and meiotic double strand breaks near the Myc oncogene on mouse chromosome 15.Genes Chromosomes Cancer2009https://conductscience.org/library/papers/19603522PubMed
19017943Deregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitors.J Immunol2008https://conductscience.org/library/papers/19017943PubMed
18242516AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.Cancer Cell2008https://conductscience.org/library/papers/18242516PubMed
18042696Epstein-Barr virus and Burkitt lymphoma.J Clin Pathol2007https://conductscience.org/library/papers/18042696PubMed
17717600B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.J Clin Invest2007https://conductscience.org/library/papers/17717600PubMed

See all 152 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6819085

GET https://conductscience.org/api/papers/v1/6819085/cited_by?page=2